Dose-finding of PB-119 Administered Subcutaneously Once Weekly Versus Placebo in Subjects With Type 2 Diabetes

Clinical trial NCT03604419 · COMPLETED

Trial details

NCT number: NCT03604419
Sponsor: PegBio Co., Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus (T2DM)

Start date: 2018-06-13
Primary completion: 2019-07-23
Enrollment: 214

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.